Marta G. Zanchi is the founder of Nina Capital and, on the firm's team page, holds the title "founder, managing partner"; the firm's team page also lists her as Chairman of the Board of Nina Capital SGEIC, S.A. Her biography on the firm's site says she was born in pre-alpine northern Italy, moved to Milan and then to California, and studied biomedical and electrical engineering from a bachelor's at Politecnico di Milano to a doctorate at Stanford University, specialising in medical instrumentation and imaging systems. It says she took the Biodesign health technology innovation class at Stanford in 2007, later joined the Stanford School of Medicine faculty and founded digital health programs at the Biodesign centre, and then created Nina Capital to invest in European need-driven founders at the intersection of healthcare and technology. She writes most of the firm's blog output under her own byline. She is named as a Board Director on the leadership page of the portfolio company MedaSystems. Her title as given in the firm's own announcements has varied over time between "founder and managing partner", "Managing Partner" and "Founding Managing Partner"; one trade outlet reporting the Fund III first close rendered it as "Founder and Managing Director".
Education
Bachelor's degree, Politecnico di Milano
Doctorate, Stanford University
Previous Experience
Stanford School of Medicine - faculty member, joining the Biodesign community and founding its digital health programs
Notable Investments
IO HealthWoodway AssuranceMedaSystems
Board Seats
MedaSystems - Board Director
Career Timeline
2007
Takes the Biodesign health technology innovation class at Stanford, per her biography on the firm's site.
2019
NINA CAPITAL SGEIC, S.A., the management company she founded, is entered on the CNMV register as number 148 on 19 July 2019.
2021
Quoted as "founder and managing partner" in the firm's 28 July 2021 announcement of five further investments and the launch of a second fund set to reach EUR 40 million.
2022
Quoted as "Founder and Managing Partner" in the firm's 16 February 2022 announcement that Fund II closed oversubscribed.
2025
Quoted at the February 2025 first close of the EUR 50 million Fund III; EU-Startups gives her title in that article as "Founder and Managing Director at Nina Capital".
2025
Quoted as "Managing Partner of Nina Capital" in the 15 October 2025 announcement of IO Health's $2M seed round, which Nina Capital led.
2026
Quoted as "Founding Managing Partner, Nina Capital" in the firm's 29 July 2026 announcement of its investment in Woodway Assurance.